4.0
23 Sept 2024
Current employee, more than 3 years
Recommend
CEO approval
Business outlook
Pros
Remote work opportunities available across functions and U.S. geographies. Good basic corporate benefits. Company is growing its U.S. presence with a new manufacturing facility in New Jersey. Strong company prospects ahead from key commercialized drug products. Generally supportive, effective, and nice culture
Cons
Uncertainties surrounding company stock and growth reflect exposure to U.S. politics regarding China. Decentralization and rapid growth have created some challenges to keeping up with effective internal infrastructures. Creating relationships across the organization can also be a challenge, reflecting a wide global geographic footprint